Ocular Surface Disease

Amniotic membrane therapy has been used in refractory cases to protect the ocular surface, modulate inflammation and fibrosis, and promote epithelial healing.

The review notes aesthetic considerations are increasingly important as social media and video conferencing spotlight facial appearance.

According to a VSP Vision Care news release, 71% say they experience performance impacts due to screen-related visual discomfort, equating to nearly one full workday of lost productivity each week.

Tonk, MD, MBA, references updates from TFOS DEWS III that promote standardized screening tools.

This evidence-based eye care podcast seeks to turn research into practical clinical decisions, with new episodes on the first Monday of each month featuring expert guests across glaucoma, retina, dry eye, AI, and more.

For the patient with ocular surface discomfort, cataract surgery becomes a process rather than a single event.

Jade Coats, OD, FAAO, and Cecelia Koetting, OD, FAAO, DipABO, provide a sneak peek into their 2-day session at the conference.

The investigators evaluated the shear-stress-dependent viscous properties of seven commercially available tear formulations. They also studied the viscosity of natural tears.

Keeping a pulse on current developments has helped optometrists look to the future

An overview of the top 10 stories from eye care for 2025.

Isocyclosporin is a dual inhibitor of transient receptor potential cation channel, mucolipin subfamily, member 2 (TRPML2), and calcineurin.

The grading scales were compiled with the goals of achieving conciseness and the ability to provide clear drug-dose-modification recommendations compared with the previous ocular CTCAE scale.

Under the terms of the agreement, Iolyx Therapeutics has granted Théa exclusive worldwide development and commercialization rights, excluding Asia, to ILYX-002 for the treatment of ocular surface diseases.

The survey was conducted by OnePoll on October 2025 and included 1000 US patients with dry eye.

Cyclosporine ophthalmic emulsion 0.05% is a topical immunomodulator to increase tear production in patients whose tear production is thought to be reduced due to ocular inflammation associated with dry eye syndrome.

Rachon, OD, FAAO, DipABO, makes the most of her optometric education through her work with residents and advocacy efforts.

Our patients benefit from a preventive approach that includes lifestyle adjustment, nutrition, and supplementation.

Ensuring proper hydration of the eye takes more moonlight and lullabies.

The drops are formulated to target bacteria that cause infections such as bacterial conjunctivitis, otitis externa, and swimmer’s ear.

Research reveals that increased exposure to green spaces significantly reduces the risk of developing dry eye disease, highlighting urban planning's vital role in public health.

A few tweaks to outdoor exercise routines can bring great relief.

The study explored the use of DMSt, used in OptiLIFT, in enhancing eyelid muscle function, improving blink dynamics, and consequently alleviating dry eye symptoms.

With this expansion, BostonSight reinforces its commitment to advancing care for patients with severe ocular surface disease and irregular corneas.

The study's primary objective was to demonstrate that LUMIFY Preservative Free redness reliever eye drops are noninferior to LUMIFY redness reliever eye drops in reducing ocular redness.

Study authors Preeya K. Gupta, MD; and Paul Karpecki, OD, formulated a case in their literature review for the routine evaluation of the upper eyelid during meibomian gland imaging.